首页> 美国卫生研究院文献>Bulletin of the World Health Organization >Antibody response to measles immunization in India
【2h】

Antibody response to measles immunization in India

机译:印度对麻疹免疫的抗体反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antibody response to measles vaccine was measured in 238 subjects aged 6-15 months. Seroconversion rates ranged from 74% at 6 months of age to 100% at 13-15 months; the differences in age-specific rates were not statistically significant. The postimmunization antibody titres increased with increasing age of the vaccinee. Seroconversion rates and antibody titres in 49 subjects with grades I and II malnutrition were not significantly different from those in the 189 normal subjects.These results support the recommendation of 9 months as a satisfactory age for commencement of measles immunization in India. However, the highest antibody levels and seroconversion rates were obtained in children over 12 months of age.
机译:在238位6-15个月的受试者中测量了对麻疹疫苗的抗体反应。血清转化率从6个月大的74%到13-15个月的100%不等;特定年龄比率的差异无统计学意义。免疫后抗体滴度随被接种者年龄的增加而增加。营养不良和I,II级营养不良的49名受试者的血清转化率和抗体滴度与189名正常受试者的血清转化率和抗体滴度没有显着差异,这些结果支持推荐9个月作为印度开始进行麻疹免疫的满意年龄。但是,在12个月以上的儿童中获得了最高的抗体水平和血清转化率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号